Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia Meeting Abstract


Authors: Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; Grever, M. R.; Altman, J. K.; Lacouture, M. E.; Rosen, N.; Berger, M.; Levine, R. L.; Abdel-Wahab, O.; Tallman, M. S.
Abstract Title: Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349233803022
PROVIDER: wos
Notes: Meeting Abstract: 24 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
MSK Authors
  1. Mario E Lacouture
    261 Lacouture
  2. Neal Rosen
    361 Rosen
  3. Martin Stuart Tallman
    408 Tallman
  4. Jae Hong Park
    132 Park
  5. Stephen Shiu-Wah Chung
    57 Chung
  6. Ross Levine
    469 Levine
  7. Michael Forman Berger
    380 Berger
  8. Helen Hyeong-Eun Won
    79 Won
  9. Young Rock Chung
    46 Chung
  10. Eunhee Kim
    28 Kim